Aims to achieve an attractive level of income combined with capital growth.
Name | % Net Assets |
---|---|
HSBC | 5.1% |
British American Tobacco | 4.4% |
Centrica | 4.3% |
Royal Dutch Shell 'B' | 4.1% |
BP | 3.5% |
Vodafone | 3.5% |
Aviva | 3.5% |
GlaxoSmithKline | 3.5% |
National Grid | 3.5% |
AstraZeneca | 3.3% |
Key | % Net Assets |
---|---|
HSBC | 5.1% |
British American Tobacco | 4.4% |
Centrica | 4.3% |
Royal Dutch Shell 'B' | 4.1% |
Other | 82.1% |
Date | 13-Nov-2024 |
---|---|
NAV | 1,687.77p |
Currency | GBP |
Change | -13.57p |
% | -0.80% |
YTD change | 8.08p |
YTD % | 0.48% |
Fund Inception | 07/04/2006 |
---|---|
Fund Manager | Pan European Equities Team |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research